Skip to content

The effect of laser therapy on knee Osteoarthritis treatment

The effect of low and high power laser therapy on pain,disability and range of motion in patients with knee osteoarthritis: a comparative clinical trial study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201502224549N8
Enrollment
50
Registered
2015-05-19
Start date
2015-04-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee joint. Primary Osteoarthritis of other joints

Interventions

Intervention 1: In the low power laser group the treatment that applied is 1 MHZ continuous mode Ultrasound with duration of 5 MIN and intensity of 1 W.CM2, TENS current with frequency of 100 HZ and
Rehabilitation
In the low power laser group the treatment that applied is 1 MHZ continuous mode Ultrasound with duration of 5 MIN and intensity of 1 W.CM2, TENS current with frequency of 100 HZ and pulse duration o
In the placebo laser group the treatment that applied is 1 MHZ continuous mode Ultrasound with duration of 5 MIN and intensity of 1 W.CM2, TENS current with frequency of 100 HZ and pulse duration of 0
In the high power laser group the treatment that applied is 1 MHZ continuous mode Ultrasound with duration of 5 MIN and intensity of 1 W.CM2, TENS current with frequency of 100 HZ and pulse duration o

Sponsors

Vice chancellor for research,Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-Unconscious chronic unilateral knee Osteoarthritis that has an intensity of 1-3 on the radio graphs. 2- Having local pain in the knee region that was greater than 4 with regard to VAS. 3- Earn a minimum score of 25 regard to the WOMAC scale. Exclusion criteria: 1- History of knee fracture, Knee tendons and ligaments injury, meniscus or knee surgery. 2- Rheumatoid arthritis. 3- Risk of bleeding. 4- Musculoskeletal disorders of hip and ankle. 5- Central and peripheral neuropathy. 6- History of physiotherapy in the last 6 months. 7- History of corticosteroid articular injection in the last 6 months. 8- Oral anti coagulation medication. 9- Unconscious patients. 10- Neoplasm. 11- Deep vein thrombosis. 12- Pacemaker. 13- Neurological deficits. 14- Severe Obesity.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before, immediately and 6 weeks after intervention. Method of measurement: Visual Analogue Scale(VAS) Questionnaire.;Range of motion. Timepoint: Before, immediately and 6 weeks after intervention. Method of measurement: Via the goniometry that show the range of motion with degree.;Disability. Timepoint: Before, immediately and 6 weeks after intervention. Method of measurement: WOMAC Western Ontario Mac Master(WOMAC) Questionnaire.;Functional ability. Timepoint: Before, immediately and 6 weeks after intervention. Method of measurement: Via the “Two minutes walk test “ that determinate the distance walked with Meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Fatemy

Semnan University of Medical Sciences

fatemyelham@yahoo.com+98 23 3334 0867

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026